Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-28

Clinical Trial Update: Bisoprolol in DMD Early Cardiomyopathy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for bisoprolol in Duchenne Muscular Dystrophy–related cardiomyopathy, currently in Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bisoprolol (Bisoprolol)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Duchenne Muscular Dystrophy, Cardiomyopathy, Dilated | Phase 2, Phase 3 | Status: UNKNOWN